Literature DB >> 33604165

Liver cancer mortality over six decades in an epidemic area: what we have learned.

Jian-Guo Chen1,2, Jian Zhu1, Yong-Hui Zhang1, Yong-Sheng Chen1, Jian-Hua Lu1, Yuan-Rong Zhu1, Hai-Zhen Chen2, Ai-Guo Shen2, Gao-Ren Wang2, John D Groopman3, Thomas W Kensler3,4.   

Abstract

BACKGROUND AND AIMS: Liver cancer is one of the most dominant malignant tumors in the world. The trends of liver cancer mortality over the past six decades have been tracked in the epidemic region of Qidong, China. Using epidemiological tools, we explore the dynamic changes in age-standardized rates to characterize important aspects of liver cancer etiology and prevention.
METHODS: Mortality data of liver cancer in Qidong from 1958 to 1971 (death retrospective survey) and from 1972 to 2017 (cancer registration) were tabulated for the crude rate (CR), and age-standardized rate and age-birth cohorts. The average annual percentage change was calculated by the Joinpoint Regression Program.
RESULTS: The natural death rate during 1958-2017 decreased from 9‰ to 5.4‰ and then increased to 8‰ as the population aged; cancer mortality rates rose continuously from 57/105 to 240/105. Liver cancer mortality increased from 20/105 to 80/105, and then dropped to less than 52/105 in 2017. Liver cancer deaths in 1972-2017 accounted for 30.53% of all cancers, with a CR of 60.48/105, age-standardized rate China (ASRC) of 34.78/105, and ASRW (world) of 45.71/105. Other key features were the CR for males and females of 91.86/105 and 29.92/105, respectively, with a sex ratio of 3.07:1. Period analysis showed that the ASRs for mortality of the age groups under 54 years old had a significant decreasing trend. Importantly, birth cohort analysis showed that the mortality rate of liver cancer in 40-44, 35-39, 30-34, 25-29, 20-24, 15-19 years cohort decreased considerably, but the rates in 70-74, and 75+ increased.
CONCLUSIONS: The crude mortality rate of liver cancer in Qidong has experienced trends from lower to higher levels, and from continued increase at a high plateau to most recently a gradual decline, and a change greatest in younger people. Many years of comprehensive prevention and intervention measures have influenced the decline of the liver cancer epidemic in this area. The reduction of intake levels of aflatoxin might be one of the most significant factors as evidenced by the dramatic decline of exposure biomarkers in this population during the past three decades. ©2021 Chen et al.

Entities:  

Keywords:  Age-standardized rate; Annual percentage change; Birth cohort; Epidemiology; Liver cancer; Mortality; Trend

Year:  2021        PMID: 33604165      PMCID: PMC7866902          DOI: 10.7717/peerj.10600

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  50 in total

Review 1.  Aflatoxins.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1993

2.  Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.

Authors:  Chao-Tung Chen; Jing-Yi Chen; Jing-Houng Wang; Kuo-Chin Chang; Po-Lin Tseng; Kwong-Ming Kee; Pao-Fei Chen; Lin-San Tsai; Shu-Chuan Chen; Sheng-Che Lin; Sheng-Nan Lu
Journal:  Kaohsiung J Med Sci       Date:  2013-02-09       Impact factor: 2.744

3.  Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice.

Authors:  Min Lian; Ying Liu; Shun-Zhang Yu; Geng-Sun Qian; Shu-Guang Wan; Kenneth-R Dixon
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

Review 4.  Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.

Authors:  Zhuanbo Luo; Lanjuan Li; Bing Ruan
Journal:  Int J Infect Dis       Date:  2011-12-17       Impact factor: 3.623

5.  Changing rates for liver and lung cancers in Qidong, China.

Authors:  Jian-Guo Chen; Thomas W Kensler
Journal:  Chem Res Toxicol       Date:  2013-11-20       Impact factor: 3.739

Review 6.  Primary prevention of hepatocellular carcinoma.

Authors:  S Z Yu
Journal:  J Gastroenterol Hepatol       Date:  1995 Nov-Dec       Impact factor: 4.029

Review 7.  Prevention and control of hepatitis B in China.

Authors:  Zongtang Sun; Lihua Ming; Xu Zhu; Jianhua Lu
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

8.  Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.

Authors:  Lihua Ming; Snorri S Thorgeirsson; Mitchell H Gail; Peixin Lu; Curtis C Harris; Nengjin Wang; Yongfu Shao; Zhiyuan Wu; Guoting Liu; Xiaohong Wang; Zongtang Sun
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

9.  Drinking water and liver cancer.

Authors:  C C Ruan; Y H Chen; Z Q Zhang
Journal:  World J Gastroenterol       Date:  1997-03-15       Impact factor: 5.742

10.  Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.

Authors:  Zhenqiu Liu; Xianhua Mao; Yanfeng Jiang; Ning Cai; Li Jin; Tiejun Zhang; Xingdong Chen
Journal:  Cancer Med       Date:  2019-08-06       Impact factor: 4.452

View more
  4 in total

1.  Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases.

Authors:  Jian-Guo Chen; Jian Zhu; Yong-Hui Zhang; Yong-Sheng Chen; Lu-Lu Ding; Hai-Zhen Chen; Ai-Guo Shen; Gao-Ren Wang
Journal:  J Hepatocell Carcinoma       Date:  2021-08-31

2.  Analysis of the Curative Effect of Continuous Nursing Based on Data Mining on Patients with Liver Tumors.

Authors:  ChunFen Peng; LiHong Bao; JingQiong Wang
Journal:  Comput Math Methods Med       Date:  2022-02-14       Impact factor: 2.238

3.  Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990-2019: a longitudinal analysis based on the global burden of disease study.

Authors:  Maedeh Amini; Mehdi Azizmohammad Looha; Elaheh Zarean; Mohamad Amin Pourhoseingholi
Journal:  BMC Public Health       Date:  2022-03-29       Impact factor: 3.295

4.  An Analysis of Microwave Ablation Parameters for Treatment of Liver Tumors from the 3D-IRCADb-01 Database.

Authors:  Marija Radmilović-Radjenović; Nikola Bošković; Martin Sabo; Branislav Radjenović
Journal:  Biomedicines       Date:  2022-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.